Overview

Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Protocol CP-4-004-EXT is designed as a long-term, open-label extension using single patient use, multi-dose, disposable pre-filled pen.
Phase:
Phase 2
Details
Lead Sponsor:
Opko Biologics
OPKO Health, Inc.
Treatments:
Hormones